Titre : Masse moléculaire

Masse moléculaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Learning Disabilities
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Masse moléculaire : Questions médicales les plus fréquentes", "headline": "Masse moléculaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Masse moléculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-08", "dateModified": "2025-05-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Masse moléculaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénomènes chimiques", "url": "https://questionsmedicales.fr/mesh/D055598", "about": { "@type": "MedicalCondition", "name": "Phénomènes chimiques", "code": { "@type": "MedicalCode", "code": "D055598", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G02" } } }, "about": { "@type": "MedicalCondition", "name": "Masse moléculaire", "alternateName": "Molecular Weight", "code": { "@type": "MedicalCode", "code": "D008970", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Dave J Adams", "url": "https://questionsmedicales.fr/author/Dave%20J%20Adams", "affiliation": { "@type": "Organization", "name": "School of Chemistry, University of Glasgow, Glasgow G12 8QQ, United Kingdom." } }, { "@type": "Person", "name": "Taro Yasumoto", "url": "https://questionsmedicales.fr/author/Taro%20Yasumoto", "affiliation": { "@type": "Organization", "name": "Division of Neurology, Department of Internal Medicine, School of Medicine, Showa University, Tokyo, Japan." } }, { "@type": "Person", "name": "Mayumi Tsuji", "url": "https://questionsmedicales.fr/author/Mayumi%20Tsuji", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, School of Medicine, Showa University, Tokyo, Japan." } }, { "@type": "Person", "name": "Shiro Nakamura", "url": "https://questionsmedicales.fr/author/Shiro%20Nakamura", "affiliation": { "@type": "Organization", "name": "Department of Oral Physiology, School of Dentistry, Showa University, Tokyo, Japan." } }, { "@type": "Person", "name": "Tomio Inoue", "url": "https://questionsmedicales.fr/author/Tomio%20Inoue", "affiliation": { "@type": "Organization", "name": "Department of Oral Physiology, School of Dentistry, Showa University, Tokyo, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Speech/Language Impairment or Specific Learning Disability? Examining the Usage of Educational Categories.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/36706457", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2022_JSLHR-21-00636" } }, { "@type": "ScholarlyArticle", "name": "An investigation into the factor structure of the Health of the Nation Outcome Scales for People with Learning Disabilities.", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37530203", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jir.13070" } }, { "@type": "ScholarlyArticle", "name": "The impact of COVID-19 on residents of long-term care facilities with learning disabilities and/or autism.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37123814", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/irv.13139" } }, { "@type": "ScholarlyArticle", "name": "Maternal age at childbirth and the risk of attention-deficit/hyperactivity disorder and learning disability in offspring.", "datePublished": "2023-02-02", "url": "https://questionsmedicales.fr/article/36817892", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2023.923133" } }, { "@type": "ScholarlyArticle", "name": "Review and update of the Health of the Nation Outcome Scales for People with Learning Disabilities (HoNOS-LD).", "datePublished": "2023-05-17", "url": "https://questionsmedicales.fr/article/37198876", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00207640231175773" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes chimiques", "item": "https://questionsmedicales.fr/mesh/D055598" }, { "@type": "ListItem", "position": 3, "name": "Masse moléculaire", "item": "https://questionsmedicales.fr/mesh/D008970" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Masse moléculaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Masse moléculaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Masse moléculaire", "description": "Comment mesure-t-on la masse moléculaire ?\nQuels instruments sont utilisés pour déterminer la masse moléculaire ?\nLa masse moléculaire est-elle importante en biologie ?\nPeut-on calculer la masse moléculaire d'une protéine ?\nQu'est-ce qu'une masse moléculaire moyenne ?", "url": "https://questionsmedicales.fr/mesh/D008970?mesh_terms=Learning+Disabilities&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Masse moléculaire", "description": "Quels symptômes peuvent indiquer une anomalie de masse moléculaire ?\nLa masse moléculaire affecte-t-elle la solubilité ?\nComment la masse moléculaire influence-t-elle l'absorption des médicaments ?\nY a-t-il des symptômes liés à des protéines de masse moléculaire élevée ?\nLes symptômes d'intolérance alimentaire sont-ils liés à la masse moléculaire ?", "url": "https://questionsmedicales.fr/mesh/D008970?mesh_terms=Learning+Disabilities&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Masse moléculaire", "description": "Comment prévenir les allergies liées à la masse moléculaire ?\nY a-t-il des mesures préventives pour les troubles métaboliques ?\nLa recherche sur la masse moléculaire peut-elle prévenir des maladies ?\nComment l'éducation nutritionnelle aide-t-elle à prévenir des problèmes liés à la masse moléculaire ?\nLes tests génétiques peuvent-ils prévenir des maladies liées à la masse moléculaire ?", "url": "https://questionsmedicales.fr/mesh/D008970?mesh_terms=Learning+Disabilities&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Masse moléculaire", "description": "Comment traiter une allergie liée à une masse moléculaire ?\nLes médicaments à masse moléculaire élevée sont-ils efficaces ?\nPeut-on modifier la masse moléculaire d'un médicament ?\nQuels traitements sont disponibles pour les troubles métaboliques ?\nComment les thérapies géniques sont-elles liées à la masse moléculaire ?", "url": "https://questionsmedicales.fr/mesh/D008970?mesh_terms=Learning+Disabilities&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Masse moléculaire", "description": "Quelles complications peuvent survenir avec des protéines de masse moléculaire élevée ?\nLes complications liées à la masse moléculaire affectent-elles le traitement ?\nComment les complications métaboliques sont-elles liées à la masse moléculaire ?\nLes complications allergiques peuvent-elles être graves ?\nQuelles sont les complications des médicaments à masse moléculaire élevée ?", "url": "https://questionsmedicales.fr/mesh/D008970?mesh_terms=Learning+Disabilities&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Masse moléculaire", "description": "Quels facteurs augmentent le risque d'allergies liées à la masse moléculaire ?\nLa génétique joue-t-elle un rôle dans les troubles liés à la masse moléculaire ?\nL'environnement influence-t-il la masse moléculaire des allergènes ?\nLe mode de vie peut-il affecter la masse moléculaire des substances ?\nQuels sont les facteurs de risque pour les maladies liées à la masse moléculaire ?", "url": "https://questionsmedicales.fr/mesh/D008970?mesh_terms=Learning+Disabilities&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesure-t-on la masse moléculaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La masse moléculaire est mesurée par des techniques comme la spectrométrie de masse." } }, { "@type": "Question", "name": "Quels instruments sont utilisés pour déterminer la masse moléculaire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des appareils comme le chromatographe et le spectromètre de masse sont utilisés." } }, { "@type": "Question", "name": "La masse moléculaire est-elle importante en biologie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à comprendre les interactions moléculaires et les réactions biochimiques." } }, { "@type": "Question", "name": "Peut-on calculer la masse moléculaire d'une protéine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en additionnant les masses atomiques des acides aminés qui la composent." } }, { "@type": "Question", "name": "Qu'est-ce qu'une masse moléculaire moyenne ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "C'est la masse moléculaire calculée pour un mélange de molécules de différentes tailles." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une anomalie de masse moléculaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des réactions allergiques ou des troubles métaboliques peuvent survenir." } }, { "@type": "Question", "name": "La masse moléculaire affecte-t-elle la solubilité ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une masse moléculaire élevée peut réduire la solubilité d'une substance dans l'eau." } }, { "@type": "Question", "name": "Comment la masse moléculaire influence-t-elle l'absorption des médicaments ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments à masse moléculaire faible sont généralement mieux absorbés par l'organisme." } }, { "@type": "Question", "name": "Y a-t-il des symptômes liés à des protéines de masse moléculaire élevée ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent causer des maladies comme l'amylose ou des troubles de la coagulation." } }, { "@type": "Question", "name": "Les symptômes d'intolérance alimentaire sont-ils liés à la masse moléculaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines intolérances peuvent être dues à des protéines de masse moléculaire élevée." } }, { "@type": "Question", "name": "Comment prévenir les allergies liées à la masse moléculaire ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les allergènes connus et consultez un allergologue pour des tests appropriés." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives pour les troubles métaboliques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain et une alimentation équilibrée peuvent aider à prévenir ces troubles." } }, { "@type": "Question", "name": "La recherche sur la masse moléculaire peut-elle prévenir des maladies ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut aider à identifier des biomarqueurs et des cibles thérapeutiques." } }, { "@type": "Question", "name": "Comment l'éducation nutritionnelle aide-t-elle à prévenir des problèmes liés à la masse moléculaire ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elle informe sur les aliments à éviter et ceux à privilégier pour une bonne santé." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils prévenir des maladies liées à la masse moléculaire ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent identifier des prédispositions à certaines maladies héréditaires." } }, { "@type": "Question", "name": "Comment traiter une allergie liée à une masse moléculaire ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des antihistaminiques et l'évitement de l'allergène identifié." } }, { "@type": "Question", "name": "Les médicaments à masse moléculaire élevée sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être efficaces, mais leur absorption et leur distribution peuvent être limitées." } }, { "@type": "Question", "name": "Peut-on modifier la masse moléculaire d'un médicament ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, par des modifications chimiques pour améliorer l'efficacité ou la biodisponibilité." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles métaboliques ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements incluent des régimes alimentaires spécifiques et des médicaments adaptés." } }, { "@type": "Question", "name": "Comment les thérapies géniques sont-elles liées à la masse moléculaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles utilisent des vecteurs de masse moléculaire spécifique pour délivrer des gènes thérapeutiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des protéines de masse moléculaire élevée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des maladies comme l'amylose ou des troubles de la coagulation." } }, { "@type": "Question", "name": "Les complications liées à la masse moléculaire affectent-elles le traitement ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent compliquer l'absorption et l'efficacité des traitements médicamenteux." } }, { "@type": "Question", "name": "Comment les complications métaboliques sont-elles liées à la masse moléculaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans la masse moléculaire des métabolites peuvent causer des dysfonctionnements." } }, { "@type": "Question", "name": "Les complications allergiques peuvent-elles être graves ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des réactions anaphylactiques potentiellement mortelles." } }, { "@type": "Question", "name": "Quelles sont les complications des médicaments à masse moléculaire élevée ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles incluent des effets secondaires, une biodisponibilité réduite et des interactions médicamenteuses." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'allergies liées à la masse moléculaire ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux d'allergies et une exposition précoce à des allergènes augmentent le risque." } }, { "@type": "Question", "name": "La génétique joue-t-elle un rôle dans les troubles liés à la masse moléculaire ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies métaboliques ont une composante génétique significative." } }, { "@type": "Question", "name": "L'environnement influence-t-il la masse moléculaire des allergènes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux comme la pollution peuvent modifier les allergènes." } }, { "@type": "Question", "name": "Le mode de vie peut-il affecter la masse moléculaire des substances ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation déséquilibrée peut influencer la composition et la masse moléculaire." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les maladies liées à la masse moléculaire ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'obésité, le diabète et des antécédents familiaux de maladies." } } ] } ] }

Sources (10000 au total)

Speech/Language Impairment or Specific Learning Disability? Examining the Usage of Educational Categories.

Developmental language disorder (DLD) is a lifelong condition that when impacting educational performance is identified and serviced through U.S. schools as outlined in the Individuals with Disabiliti... We analyzed publicly available data released by the U.S. Department of Education from six school years between 2010 and 2020. We examined the use of S/LI and SLD categories across students of differen... We present a trend in which younger students tend to be identified with the S/LI category, whereas older students tend to be identified with the SLD category. This trend is evident in all 6 years of d... We discuss these findings in the context of research on language disorders to explain this trend. We highlight the potential damaging effects of using inconsistent terminology, including affecting the...

An investigation into the factor structure of the Health of the Nation Outcome Scales for People with Learning Disabilities.

The Health of the Nation Outcome Scales for People with Learning Disabilities (HoNOS-LD) is one of the most used outcome measures in learning disability services in the United Kingdom. There is relati... A data set of HoNOS-LD scales from 571 people with learning disabilities was randomly split into two halves. Exploratory Mokken analysis was applied to the first dataset, and confirmatory scale factor... Two-factor and three-factor solutions were explored in the Mokken analysis, with the three-factor option having somewhat better characteristics. One-factor, three-factor and seven-factor solutions wer... The HoNOS-LD is best conceptualised as consisting of three scales, accounting for 14 items that can be labelled as 'Cognitive and Physical Functioning', 'Behaviour and Mood Disturbances' and 'Function...

The impact of COVID-19 on residents of long-term care facilities with learning disabilities and/or autism.

The COVID-19 pandemic has had disproportionate impact on vulnerable populations including those with learning disabilities. Assessing the incidence and risk of death in such settings can improve the p... Surveillance records for COVID-19 infections in England from 02 February 2020 to 31 March 2022 were extracted. Data on property type, variant wave, vaccination, hospitalisation and death were derived ... A total of 3501 individuals were identified as diagnosed with SARS-CoV-2 whilst living in 632 care home properties for learning disabilities and/or autism. Of the 3686 episodes of infection, 80.4% wer... Care home residents with learning disabilities and/or autism have a greater risk of death from COVID-19. Optimising guidance to meet their needs is of great importance....

Maternal age at childbirth and the risk of attention-deficit/hyperactivity disorder and learning disability in offspring.

Studies have shown that young maternal age at childbirth can increase the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring, but a study of the U.S. population has not been reported... This study evaluated the association between young and advanced maternal age at childbirth and offspring risk of ADHD and LD in the U.S. population. Using data from 8,098 participants included in the ... Among all participants, the offspring of subjects with a maternal age at childbirth of 18-24 years had an increased risk of ADHD (OR = 1.34, 95% CI: 1.01, 1.79) and LD (OR = 1.36, 95% CI: 1.06, 1.79) ... These results provide epidemiological evidence showing that young and advanced maternal age at childbirth are associated with ADHD and LD risk....

Review and update of the Health of the Nation Outcome Scales for People with Learning Disabilities (HoNOS-LD).

The Health of the Nation Outcomes Scales for people with Learning Disabilities (HoNOS-LD) is an 18-item measure which provides a structured and standardized approach to rating various clinical and psy... To revise and improve the HoNOS-LD's utility in contemporary intellectual disability (ID) services whilst retaining its original objectives and five-point severity ratings.... ID clinicians were invited to complete an online survey, rating each item on the existing measure for being fit for purpose, identifying issues and suggesting improvements based on their experience of... A total of 75 individuals replied. Respondents had used HoNOS-LD for an average of 8.0 years (... The changes outlined in this paper are based on the advisory group's expert consensus. These changes are intended to improve reliability and validity but now need empirical testing as well as review b...

Approaches used to prevent and reduce the use of restrictive practices on adults with learning disabilities: Protocol for a realist review.

The use of restrictive practices has significant adverse effects on the individual, care providers and organisations. This review will describe how, why, for whom, and in what circumstances approaches... Evidence from the literature will be synthesised using a realist review approach - an interpretative, theory-driven approach to understand how complex healthcare approaches work in reducing the use of... Findings will be used to provide recommendations for practice and policymaking.... In accordance with the guidelines, this realist review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on 4th December 2019 (CRD42019158432)....

Dissociative Trait as a Mediator of Problematic Internet Use in Children with attention-deficit/hyperactivity Disorder and Learning Disabilities.

This study used data from a national birth cohort study to investigate the duration of internet use at the age of 12 years among children diagnosed with attention-deficit/hyperactivity disorder (ADHD)... The 5.5- and 12-year-old Taiwan Birth Cohort Study dataset was used (N = 17,694).... More boys were diagnosed with LDs, IDs, ADHD and ASD; however, girls were at increased likelihood of PIU. ID and ASD diagnoses were not associated with increasing PIU likelihood. However, children who... Dissociative absorption was found to be a mediating factor between childhood diagnosis and PIU and can be used as a screening indicator in prevention programs to reduce the duration and severity of PI...

Attention-Deficit Hyperactivity Disorder and Learning Disabilities Modify Recovery and Sport Behavior Following Sport-Related Concussion.

Limited evidence exists concerning how a diagnosis of attention-deficit hyperactivity disorder and/or learning disabilities (ADHD/LD) modifies recovery and behavior following sport-related concussion ...